$2.65 Billion is the total value of HealthCor Management, L.P.'s 52 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 53.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EW | Buy | EDWARDS LIFESCIENCES CORP | $137,661,000 | +19.8% | 625,990 | +0.6% | 5.20% | +16.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $134,577,000 | -32.8% | 1,493,480 | -37.0% | 5.09% | -34.5% |
| MRK | Buy | MERCK & CO INC | $131,177,000 | +21.0% | 1,558,290 | +20.6% | 4.96% | +17.9% |
| BIIB | New | BIOGEN INCcall | $128,051,000 | – | 550,000 | +100.0% | 4.84% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $126,994,000 | – | 235,205 | +100.0% | 4.80% | – |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $115,153,000 | +16.6% | 679,690 | +26.2% | 4.35% | +13.6% |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $99,297,000 | – | 723,370 | +100.0% | 3.75% | – |
| DHR | Buy | DANAHER CORPORATION | $99,221,000 | +36.7% | 686,980 | +35.3% | 3.75% | +33.2% |
| BAX | New | BAXTER INTL INC | $90,341,000 | – | 1,032,820 | +100.0% | 3.42% | – |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $88,912,000 | -17.8% | 1,031,220 | -0.1% | 3.36% | -19.9% |
| CVRS | CORINDUS VASCULAR ROBOTICS I | $85,521,000 | +43.6% | 19,981,655 | 0.0% | 3.23% | +40.0% | |
| UNH | Sell | UNITEDHEALTH GROUP INC | $85,522,000 | -11.8% | 393,530 | -1.0% | 3.23% | -14.1% |
| BIIB | New | BIOGEN INC | $83,084,000 | – | 356,860 | +100.0% | 3.14% | – |
| NVRO | Sell | NEVRO CORP | $82,000,000 | +3.0% | 953,820 | -22.3% | 3.10% | +0.4% |
| LH | New | LABORATORY CORP AMER HLDGS | $79,545,000 | – | 473,480 | +100.0% | 3.01% | – |
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $71,583,000 | +6.5% | 2,628,840 | -5.9% | 2.71% | +3.8% |
| ABT | Sell | ABBOTT LABS | $63,288,000 | -34.2% | 756,400 | -33.9% | 2.39% | -35.9% |
| MDT | Sell | MEDTRONIC PLC | $58,085,000 | +3.1% | 534,750 | -7.5% | 2.20% | +0.5% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $56,679,000 | -37.9% | 1,117,710 | -44.5% | 2.14% | -39.5% |
| CHNG | Buy | CHANGE HEALTHCARE INC | $51,394,000 | +30.9% | 4,254,430 | +58.1% | 1.94% | +27.5% |
| HCA | Sell | HCA HEALTHCARE INC | $49,039,000 | -13.5% | 407,230 | -2.9% | 1.85% | -15.7% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $48,363,000 | -6.5% | 365,360 | +0.3% | 1.83% | -8.9% |
| BLUE | Buy | BLUEBIRD BIO INC | $46,561,000 | -0.6% | 507,090 | +37.8% | 1.76% | -3.1% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $44,774,000 | +24.1% | 609,417 | +59.3% | 1.69% | +20.9% |
| JNJ | New | JOHNSON & JOHNSON | $44,447,000 | – | 343,540 | +100.0% | 1.68% | – |
| XENT | Sell | INTERSECT ENT INC | $43,233,000 | -31.6% | 2,541,630 | -8.4% | 1.63% | -33.3% |
| WMGI | Buy | WRIGHT MED GROUP N V | $42,546,000 | +1326.8% | 2,062,360 | +1962.4% | 1.61% | +1286.2% |
| CNMD | Sell | CONMED CORP | $41,047,000 | +5.4% | 426,910 | -6.2% | 1.55% | +2.7% |
| IQV | Buy | IQVIA HLDGS INC | $40,923,000 | -0.6% | 273,950 | +7.0% | 1.55% | -3.2% |
| HOLX | New | HOLOGIC INC | $40,875,000 | – | 809,570 | +100.0% | 1.54% | – |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $39,136,000 | -38.1% | 961,820 | -34.6% | 1.48% | -39.7% |
| ALC | Buy | ALCON INC | $32,581,000 | -0.3% | 558,940 | +6.1% | 1.23% | -2.8% |
| GILD | Sell | GILEAD SCIENCES INC | $30,608,000 | -40.6% | 482,930 | -36.7% | 1.16% | -42.2% |
| HAE | Sell | HAEMONETICS CORP | $26,700,000 | -36.6% | 211,670 | -39.6% | 1.01% | -38.3% |
| BMY | Sell | BRISTOL MYERS SQUIBB COcall | $20,284,000 | -25.5% | 400,000 | -33.3% | 0.77% | -27.4% |
| QGEN | New | QIAGEN NV | $20,247,000 | – | 614,110 | +100.0% | 0.76% | – |
| NUVA | Buy | NUVASIVE INC | $19,071,000 | +30.5% | 300,905 | +20.5% | 0.72% | +27.2% |
| SYK | Buy | STRYKER CORP | $18,838,000 | +174.8% | 87,090 | +161.1% | 0.71% | +167.7% |
| HUM | Sell | HUMANA INC | $17,915,000 | -89.5% | 70,070 | -89.1% | 0.68% | -89.8% |
| MYOK | Sell | MYOKARDIA INC | $14,711,000 | -16.3% | 282,090 | -19.5% | 0.56% | -18.5% |
| VRAY | Buy | VIEWRAY INC | $14,181,000 | -64.7% | 4,890,100 | +7.1% | 0.54% | -65.6% |
| GMAB | New | GENMAB A Ssponsored ads | $14,118,000 | – | 696,835 | +100.0% | 0.53% | – |
| SEM | Sell | SELECT MED HLDGS CORP | $13,669,000 | -14.3% | 824,900 | -17.9% | 0.52% | -16.5% |
| STML | Buy | STEMLINE THERAPEUTICS INC | $12,948,000 | -21.0% | 1,243,780 | +16.2% | 0.49% | -23.1% |
| NVST | New | ENVISTA HLDGS CORP | $8,364,000 | – | 300,000 | +100.0% | 0.32% | – |
| RTIX | New | RTI SURGICAL HOLDINGS INC | $6,152,000 | – | 2,158,644 | +100.0% | 0.23% | – |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $5,861,000 | -76.1% | 1,491,376 | -9.5% | 0.22% | -76.7% |
| ZGNX | New | ZOGENIX INC | $5,245,000 | – | 130,990 | +100.0% | 0.20% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $4,445,000 | – | 832,370 | +100.0% | 0.17% | – |
| NGM | Sell | NGM BIOPHARMACEUTICALS INC | $4,386,000 | -12.5% | 316,679 | -7.6% | 0.17% | -14.9% |
| PSNL | Sell | PERSONALIS INC | $4,160,000 | -48.9% | 283,500 | -5.5% | 0.16% | -50.3% |
| PTE | Buy | POLARITYTE INC | $2,055,000 | -37.3% | 636,110 | +10.6% | 0.08% | -38.6% |
| AXLA | Exit | AXCELLA HEALTH INC | $0 | – | -170,645 | -100.0% | -0.06% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -119,484 | -100.0% | -0.12% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.21% | – |
| ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES COR | $0 | – | -120,000 | -100.0% | -0.22% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -425,820 | -100.0% | -0.34% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -250,000 | -100.0% | -0.51% | – |
| PFE | Exit | PFIZER INCput | $0 | – | -500,000 | -100.0% | -0.84% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -1,242,850 | -100.0% | -1.18% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -121,270 | -100.0% | -1.19% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -468,540 | -100.0% | -1.32% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -151,220 | -100.0% | -1.66% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -205,510 | -100.0% | -2.18% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -3,047,910 | -100.0% | -2.29% | – |
| ELAN | Exit | ELANCO ANIMAL HEALTH INC | $0 | – | -2,879,010 | -100.0% | -3.78% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.